G-Supress DX (KRAMER NOVIS)
Welcome to the PulseAid listing for the G-Supress DX drug offered from KRAMER NOVIS. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | KRAMER NOVIS |
NON-PROPRIETARY NAME: | Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride |
SUBSTANCE NAME: | GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | SYRUP |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2011-03-29 |
END MARKETING DATE: | 0000-00-00 |
G-Supress DX HUMAN OTC DRUG Details:
Item Description | G-Supress DX from KRAMER NOVIS |
LABELER NAME: | KRAMER NOVIS |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50; 5; 2.5(mg/mL; mg/mL; mg/mL) |
START MARKETING DATE: | 2011-03-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52083-655_2bea2903-0939-4a04-ac0d-f4913b6e0a24 |
PRODUCT NDC: | 52083-655 |
APPLICATION NUMBER: | part341 |
Other GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: